HALOZYME COMMENCES TENDER OFFER FOR ALL OUTSTANDING SHARES OF COMMON STOCK OF ANTARES PHARMA

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that it is commencing, through a wholly owned subsidiary, Atlas Merger...

Related Keywords

San Diego ,California ,United States ,Washington ,Schottlandt Claudia Styslinger ,Wilkinson Brimmer Katcher ,Eli Lilly ,Bristol Myers Squibb ,Joele Frank ,Halozyme Investor Relations Department ,Linkedin ,Atlas Merger Sub Inc ,Df King Co Inc ,Twitter ,Drug Administration ,Antare Investor Relations Department ,Nasdaq ,Halozyme Therapeutics Inc ,Exchange Commission ,Pfizer ,Antares Pharma Inc ,Halozyme Therapeutics ,Atlas Merger Sub ,Antares Pharma ,Horizon Therapeutics ,Viiv Healthcare ,Statement Regarding Forward Looking ,Recommendation Statement ,Investor Relations Department ,Kelly Sullivan ,Ramy Feng ,Wilkinson Brimmer ,Nc ,